Skip to main content Skip to main menu
UF Health UF Health Monogram University of Florida
UF monogram
Diabetes Institute University of Florida
Give Online Now

Main Navigation

  • Home
  • About
    • About Overview
    • Leadership and Staff
      • Director's Welcome
      • Executive Council
      • Student Ambassadors
    • University of Florida Firsts
    • Sign Up for Emails
    • Publications
  • News & Events
    • News & Events Overview
    • Friends for Life 2020
    • Bluevember
      • 2019 Bluevember Events
      • 2020 Bluevember Events
      • 2021 Bluevember Events
      • 2022 Bluevember Events
    • Seminar Series
      • 2022-2023 Seminars
      • 2021-2022 Seminars
      • 2020-2021 Seminars
      • 2019-2020 Seminars
      • 2018- 2019 Seminars
  • Research
    • Research Overview
    • Scientific Publications
    • Programs
    • Participate in Our Research
  • Patient Care
    • Patient Care Overview
    • Services
      • Pediatric Diabetes
      • Adult Diabetes
    • Resources
  • Education
    • Education Overview
    • Education & Training Programs
      • T32 Training Program in Type 1 Diabetes and Biomedical Engineering
    • Education Resources
  • Community
    • Community Overview
    • Resources
    • UF College Students with Diabetes
  • Members
    • Members Overview
    • Become a Member
    • Member Directory
    • Member Resources
      • UFDI Slide Decks
  • Give
  1. Research
  2. Participate in Our Research
  3. New Onset T1D Studies
Research Overview
  • Scientific Publications
  • Programs
  • Participate in Our Research

New Onset T1D Studies

Study NamePrincipal Investigator
Long Term Investigative Follow-Up in TrialNet (LIFT) StudyDesmond Schatz, M.D.
Immune Function During Various Stages of Insulin Dependent DiabetesMark Atkinson, Ph.D.
Non-Invasive Assessment of Pancreatic Volume as a Tool to Augment Risk Stratification in Patients at Risk for Type 1 DiabetesMichael Haller, M.D.
A Study of SIMPONIĀ® to Arrest Beta-cell Loss in Type 1 Diabetes (T1GER)
Lactobacillus Johnsonii Supplementation in Children and Adults With T1DMichael Haller, M.D.
DiabeteS AUtoimmuNity WithdRawn In New OnSEt and In Established Patients (SUNRISE) A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients with New Onset or Established Type 1 Diabetes MellitusLaura Jacobsen, M.D.
UF monogram
Diabetes Institute University of Florida
Physical Address
1275 Center Drive, Room J593, P.O. Box 100309
Gainesville, FL 32610
Email
uf-diabetes@ufl.edu
Gift Icon

Make a Gift

Giving Opportunities
Social Media
Facebook Twitter
University of Florida Health - Home UF Health Logo
University of Florida - Home UF Logo
  • Log in
  • Website Support
  • Sitemap
  • Disclaimer & Permitted Use
  • Disability Services
  • Security Policies
  • UF Privacy Policy
  • Shands Privacy Policy
  • This page uses Google Analytics (Google Privacy Policy)

© 2023 University of Florida Health